Saint Vincent and the Grenadines vs Tonga: New cases tested for RR-/MDR-TB
Saint Vincent and the Grenadines
100.0%
in 2023
Tonga
100.0%
in 2023
Saint Vincent and the Grenadines rank
1st
Tonga rank
1st
New cases tested for RR-/MDR-TB over time
- Saint Vincent and the Grenadines
- Tonga
How they compare
Saint Vincent and the Grenadines currently reports 100.0% against 100.0% in Tonga, a difference of 0.0%.
The two have swapped places 1 time across 12 shared years of data; in 2010 it was Saint Vincent and the Grenadines ahead.
Saint Vincent and the Grenadines ranks 1st and Tonga ranks 1st of 192 countries.
Across the 2 decades both report, Saint Vincent and the Grenadines averaged higher in 1 and Tonga in 1.
Head to head by decade
| Decade | Saint Vincent and the Grenadines | Tonga | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 72.8% | 12.5% | 60.2% | Saint Vincent and the Grenadines |
| 2020s | 75.0% | 100.0% | 25.0% | Tonga |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Saint Vincent and the Grenadines or Tonga?
- Saint Vincent and the Grenadines, at 100.0% against 100.0% in Tonga as of 2023.
- What is the difference in new cases tested for rr-/mdr-tb between Saint Vincent and the Grenadines and Tonga?
- 0.0%, with Saint Vincent and the Grenadines ahead.
- How many years of comparable data are there for Saint Vincent and the Grenadines and Tonga?
- 12 years are reported by both, from 2010 to 2023.
- How do Saint Vincent and the Grenadines and Tonga rank globally for new cases tested for rr-/mdr-tb?
- Saint Vincent and the Grenadines ranks 1st and Tonga ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.